Primary cutaneous B-cell lymphomas: A practical approach

Hematology/Oncology Clinics of North America

Volumn 17, Issue 6, 2003, Pages 1333-1350

  Demierre, Marie France ^a,b   Kerl, Helmut ^c   Willemze, Rein ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; PREDNISONE; RITUXIMAB; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ANTIGEN EXPRESSION; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLONAL VARIATION; CUTANEOUS B CELL LYMPHOMA; DIAGNOSTIC APPROACH ROUTE; FOLLICLE CELL LYMPHOMA; GENETIC DAMAGE; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOMA; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; PATHOGENESIS; PLASMACYTOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN LYMPHOMA; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION;

EID: 0345735914     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(03)00118-7     Document Type: Review

References (55)

1. Kerl K, Rauch HJ, Hodl ST. Cutaneous B-cell lymphomas. In: Goos M, Christophers E, editors. Lymphoproliferative diseases of the skin. Berlin: Springer; 1982. p. 179-91.
2. Willemze R, Kerl H, Sterry W. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90(1):354-71.
3. Zackheim HS, Vonderheid EC, Ramsay DL, et al. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000;43(5 Pt 1):793-6.
4. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999;341(24):1817-28.
5. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Cancer 1991;67:2311-26.
6. Asadullah K, Gellrich S, Haeussler-Quade A, et al. Cytokine expression in primary cutaneous germinal center cell lymphomas. Exp Dermatol 2000;9(1):71-6.
7. Isaacson PG. Recent developments in our understanding of gastric lymphomas. Am J Surg Pathol 1996;20(Suppl 1):S1-7.
8. Norton AJ. Classification of cutaneous lymphoma: a critical appraisal of recent proposals. Am J Dermatopathol 1999;21(3):279-87.
9. Cerroni L, Zochling N, Putz B, et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997;24(8):457-61.
10. Garbe C, Stein H, Dienemann D, et al. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991;24(4):584-90.
11. Kutting B, Bonsmann G, Metze D, et al. Borrelia burgdorferi-associated primary cutaneous B-cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 1997;36:311-4.
12. Goodlad JR, Krajewski AS, Batstone PJ, et al. Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol 2002;26(6):733-41.
13. Fink-Puches R, Zenahlik P, Back B, et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002;99(3):800-5.
14. Wood GS, Kamath NV, Guitart J, et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol 2001;28(10):502-7.
15. Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985;41(3):899-906.
16. Tsujimoto Y, Yunis J, Onorato-Showe L, et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984;224(4656):1403-6.
17. Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317(19):1185-9.
18. Volkenandt M, Cerroni L, Rieger E, et al. Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reaction. J Cutan Pathol 1992;19(5):353-6.
19. Yang B, Tubbs RR, Finn W, et al. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol 2000;24(5):694-702.
20. Child FJ, Russell-Jones R, Woolford AJ, et al. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol 2001;144(4):735-44.
21. Geelen FA, Vermeer MH, Meijer CJ, et al. Bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 1998;16(6):2080-5.
22. Child FJ, Scarisbrick JJ, Calonje E, et al. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma. J Invest Dermatol 2002;118(6):941-8.
23. Pimpinelli N, Santucci M, Bosi A, et al. Primary cutaneous follicular centre-cell lymphoma - a lymphoproliferative disease with favourable prognosis. Clin Exp Dermatol 1989;14(1):12-9.
24. Pimpinelli N, Santucci M, Mori M, et al. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity? J Am Acad Dermatol 1997;37(6):1012-6.
25. Rijlaarsdam JU, Toonstra J, Meijer OW, et al. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 1996;14(2):549-55.
26. Kerl H, Cerroni L. Primary B-cell lymphomas of the skin. Ann Oncol 1997;8(Suppl 2):29-32.
27. Grange F, Bekkenk MW, Wechsler J, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol 2001;19(16):3602-10.
28. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36(1):69-86.
29. Cerroni L, Kerl H, Gatter K. An illustrated guide to skin lymphoma. Oxford (UK): Blackwell Science; 1998.
30. Cerroni L, Arzberger E, Putz B, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000;95(12):3922-8.
31. Cerroni L, Signoretti S, Hofler G, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997;21(11):1307-15.
32. Rijlaarsdam JU, van der Putte SC, Berti E, et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 1993;23(2):117-25.
33. Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101:2335-9.
34. Vermeer MH, Geelen FA, van Haselen CW, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol 1996;132(11):1304-8.
35. Willemze R, Kruyswijk MR, De Bruin CD, et al. Angiotropic (intravascular) large cell lymphoma of the skin previously classified as malignant angioendotheliomatosis. Br J Dermatol 1987;116(3):393-9.
36. Burg G, Kempf W, Haeffner AC, et al. Cutaneous lymphomas. Curr Prob Dermatol 1997;9:137-204.
37. Pimpinelli N, Santucci M, Carli P, et al. Primary cutaneous follicular center cell lymphoma: clinical and histological aspects. Curr Probl Dermatol 1990;19:203-20.
38. Willemze R, Meijer CJ, Sentis HJ, et al. Primary cutaneous large cell lymphomas of follicular center cell origin. A clinical follow-up study of nineteen patients. J Am Acad Dermatol 1987;16(3 Pt 1):518-26.
39. Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin Cutan Med Surg 2000;19(2): 133-41.
40. Rijlaarsdam JU, Meijer CJ, Willemze R. Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. A comparative clinicopathologic study of 57 patients. Cancer 1990;65(10):2301-6.
41. Willemze R, Meijer CJ. Analysis of non-neoplastic cells in cutaneous B-cell lymphomas. J Dermatol Surg Oncol 1984;10(4):315-8.
42. de Leval L, Harris NL, Longtine J, et al. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol 2001;25(6):732-41.
43. Garcia CF, Weiss LM, Warnke RA, et al. Cutaneous follicular lymphoma. Am J Surg Pathol 1986;10(7):454-63.
44. Pandolfino TL, Siegel RS, Kuzel TM, et al. Primary cutaneous B-cell lymphoma: review and current concepts. J Clin Oncol 2000;18(10):2152-68.
45. Cleary ML, Chao J, Warnke R, et al. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 1984;81(2):593-7.
46. Weiss LM, Wood GS, Nickoloff BJ, et al. Gene rearrangement studies in lymphoproliferative disorders of skin. Adv Dermatol 1988;3:141-60.
47. Zelickson BD, Peters MS, Pittelkow MR. Gene rearrangement analysis in lymphoid neoplasia. Clin Dermatol 1991;9(2):119-28.
48. Kluin PM, van Krieken JH. The molecular biology of B-cell lymphoma: clinicopathologic implications. Ann Hematol 1991;62(4):95-102.
49. Shapiro M, Yun M, Junkins-Hopkins M, et al. Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T-and B-cell lymphomas. J Am Acad Dermatol 2002;47:623-8.
50. Kerl H, Fink-Punches R, Cerroni L. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas. Keio J Med 2001;50:269-73.
51. Bekkenk MW, Vermeer MH, Geerts ML, et al. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients. J Clin Oncol 1999;17(8):2471-8.
52. Zenahlik P, Fink Puches R, Kapp KS, et al. Die therapie der primaren kutanen B-zell lymphome. [Therapy of primary cutaneous B-cell lymphomas]. Hautarzt 2000;51:19-24.
53. Paul T, Radny P, Krober SM, et al. Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol 2001;144(6):1239-43.
54. Heinzerling LM, Urbanek M, Funk JO, et al. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer 2000;89(8):1835-44.
55. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346(4):235-42.